231 related articles for article (PubMed ID: 37175974)
1. MicroRNA Dysregulation in Early Breast Cancer Diagnosis: A Systematic Review and Meta-Analysis.
Garrido-Palacios A; Rojas Carvajal AM; Núñez-Negrillo AM; Cortés-Martín J; Sánchez-García JC; Aguilar-Cordero MJ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175974
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of seven biomarkers for breast cancer: an overview with evidence mapping and indirect comparisons of diagnostic test accuracy.
Gao Y; Liu M; Shi S; Sun Y; Li M; Zhang M; Sheng Z; Zhang J; Tian J;
Clin Exp Med; 2020 Feb; 20(1):97-108. PubMed ID: 31894424
[TBL] [Abstract][Full Text] [Related]
5. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
Zhang L; Xu Y; Jin X; Wang Z; Wu Y; Zhao D; Chen G; Li D; Wang X; Cao H; Xie Y; Liang Z
Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
[TBL] [Abstract][Full Text] [Related]
6. Clinical Theragnostic Relationship between Drug-Resistance Specific miRNA Expressions, Chemotherapeutic Resistance, and Sensitivity in Breast Cancer: A Systematic Review and Meta-Analysis.
Jayaraj R; Nayagam SG; Kar A; Sathyakumar S; Mohammed H; Smiti M; Sabarimurugan S; Kumarasamy C; Priyadharshini T; Gothandam KM; Ramesh N; Gupta A; Baxi S; Swamiappan S; Krishnan S
Cells; 2019 Oct; 8(10):. PubMed ID: 31615089
[TBL] [Abstract][Full Text] [Related]
7. Candidate miRNAs in human breast cancer biomarkers: a systematic review.
Adhami M; Haghdoost AA; Sadeghi B; Malekpour Afshar R
Breast Cancer; 2018 Mar; 25(2):198-205. PubMed ID: 29101635
[TBL] [Abstract][Full Text] [Related]
8. Assessing the Role of MicroRNAs in Predicting Breast Cancer Recurrence-A Systematic Review.
Bouz Mkabaah L; Davey MG; Lennon JC; Bouz G; Miller N; Kerin MJ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108278
[TBL] [Abstract][Full Text] [Related]
9. Serum microRNA-21 as a potential diagnostic biomarker for breast cancer: a systematic review and meta-analysis.
Li S; Yang X; Yang J; Zhen J; Zhang D
Clin Exp Med; 2016 Feb; 16(1):29-35. PubMed ID: 25516467
[TBL] [Abstract][Full Text] [Related]
10. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
Zhang K; Wang YW; Wang YY; Song Y; Zhu J; Si PC; Ma R
Gene; 2017 Jul; 619():10-20. PubMed ID: 28359916
[TBL] [Abstract][Full Text] [Related]
11. Novel circulating microRNA signature as a potential non-invasive multi-marker test in ER-positive early-stage breast cancer: a case control study.
Kodahl AR; Lyng MB; Binder H; Cold S; Gravgaard K; Knoop AS; Ditzel HJ
Mol Oncol; 2014 Jul; 8(5):874-83. PubMed ID: 24694649
[TBL] [Abstract][Full Text] [Related]
12. Tumor microRNA expression profiling identifies circulating microRNAs for early breast cancer detection.
Matamala N; Vargas MT; González-Cámpora R; Miñambres R; Arias JI; Menéndez P; Andrés-León E; Gómez-López G; Yanowsky K; Calvete-Candenas J; Inglada-Pérez L; Martínez-Delgado B; Benítez J
Clin Chem; 2015 Aug; 61(8):1098-106. PubMed ID: 26056355
[TBL] [Abstract][Full Text] [Related]
13. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
Xiong DD; Lv J; Wei KL; Feng ZB; Chen JT; Liu KC; Chen G; Luo DZ
Oncol Rep; 2017 Jun; 37(6):3297-3304. PubMed ID: 28440475
[TBL] [Abstract][Full Text] [Related]
14. A two-miRNA signature of upregulated miR-185-5p and miR-362-5p as a blood biomarker for breast cancer.
Zhang K; Wang YY; Xu Y; Zhang L; Zhu J; Si PC; Wang YW; Ma R
Pathol Res Pract; 2021 Jun; 222():153458. PubMed ID: 33962174
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
Orangi E; Motovali-Bashi M
Gene; 2019 Mar; 687():272-279. PubMed ID: 30468908
[TBL] [Abstract][Full Text] [Related]
16. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
Arabkari V; Clancy E; Dwyer RM; Kerin MJ; Kalinina O; Holian E; Newell J; Smith TJ
Pathol Oncol Res; 2020 Apr; 26(2):833-844. PubMed ID: 30840191
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
Nassar FJ; Nasr R; Talhouk R
Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-21 as a potential diagnostic biomarker for breast cancer patients: a pooled analysis of individual studies.
Gao Y; Cai Q; Huang Y; Li S; Yang H; Sun L; Chen K; Wang Y
Oncotarget; 2016 Jun; 7(23):34498-506. PubMed ID: 27153564
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of diagnostic cell-free circulating microRNAs for breast cancer detection.
Sehovic E; Urru S; Chiorino G; Doebler P
BMC Cancer; 2022 Jun; 22(1):634. PubMed ID: 35681127
[TBL] [Abstract][Full Text] [Related]
20. Association of microRNA-21 expression with breast cancer subtypes and its potential as an early biomarker.
Lee SH; Brianna
Pathol Res Pract; 2024 Feb; 254():155073. PubMed ID: 38218039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
